Beranda › Kanker Paru Non-Sel Kecil › Pennsylvania › Reading
Uji klinis Kanker Paru Non-Sel Kecil di Reading, PA
9 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Reading (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Reading Hospital, West Reading · 1 mi jauhnya
- Ephrata Cancer Center, Ephrata · 17 mi jauhnya
- Sechler Family Cancer Center, Lebanon · 26 mi jauhnya
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Menerima pesertaFase 3
- Reading Hospital, West Reading · 1 mi jauhnya
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- McGlinn Cancer Institute Reading Hospital, West Reading · 1 mi jauhnya
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Reading Hospital - McGlinn Cancer Institute, West Reading · 1 mi jauhnya
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Ephrata Cancer Center, Ephrata · 17 mi jauhnya
- Sechler Family Cancer Center, Lebanon · 26 mi jauhnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Ephrata Cancer Center, Ephrata · 17 mi jauhnya
- Sechler Family Cancer Center, Lebanon · 26 mi jauhnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Ephrata Cancer Center, Ephrata · 17 mi jauhnya
- Sechler Family Cancer Center, Lebanon · 26 mi jauhnya
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Ephrata Cancer Center, Ephrata · 17 mi jauhnya
- Sechler Family Cancer Center, Lebanon · 26 mi jauhnya
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Ephrata Cancer Center, Ephrata · 17 mi jauhnya
- Sechler Family Cancer Center, Lebanon · 26 mi jauhnya
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY120 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH56 studi
- Washington, DC55 studi
Studi lain di Reading
- Kanker Paru11 studi
- Leukemia Mieloid Akut5 studi
- Kanker Payudara5 studi
- Gangguan Somnolen Berlebih5 studi
- Kanker Prostat4 studi
- Kanker (semua jenis)4 studi
- Kanker Kolorektal3 studi
- Narkolepsi3 studi
- Gangguan Tidur3 studi
- Kelelahan3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.